Co-Encapsulation of Curcumin and Doxorubicin in Albumin Nanoparticles Blocks the Adaptive Treatment Tolerance of Cancer Cells
Biophysics Reports
doi 10.1007/s41048-018-0079-6
Full Text
Open PDFAbstract
Available in full text
Date
January 11, 2019
Authors
Publisher
Springer Science and Business Media LLC